期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease 被引量:10
1
作者 Nadia Panera daniela gnani +3 位作者 Annalisa Crudele Sara Ceccarelli Valerio Nobili Anna Alisi 《World Journal of Gastroenterology》 SCIE CAS 2014年第41期15079-15086,共8页
Non-alcoholic fatty liver disease(NAFLD) is a multi-faceted condition including simple steatosis alone or associated with inflammation and ballooning(non-alcoholic steatohepatitis) and eventually fibrosis.The NAFLD in... Non-alcoholic fatty liver disease(NAFLD) is a multi-faceted condition including simple steatosis alone or associated with inflammation and ballooning(non-alcoholic steatohepatitis) and eventually fibrosis.The NAFLD incidence has increased over the last twenty years becoming the most frequent chronic liver disease in industrialized countries.Obesity,visceral adiposity,insulin resistance,and many other disorders that characterize metabolic syndrome are the major predisposing risk factors for NAFLD.Furthermore,different factors,including genetic background,epigenetic mechanisms and environmental factors,such as diet and physical exercise,contribute to NAFLD development and progression.Several lines of evidence demonstrate that specific microRNAs expression profiles are strongly associated with several pathological conditions including NAFLD.In NAFLD,microRNA deregulation in response to intrinsic genetic or epigenetic factors or environmental factors contributes to metabolic dysfunction.In this review we focused on microRNAs role both as controlled and controllers molecules in NAFLD development and/or their eventual value as non-invasive biomarkers of disease. 展开更多
关键词 Liver steatosis FIBROSIS Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis MICRORNAS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部